Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

United Therapeutics (UTHR)

Add to Watchlists
Create an Alert
93.63 -2.30  -2.40% NASDAQ Apr 23, 4:59PM BATS Real time Currency in USD

United Therapeutics Research and Development Expense (Quarterly):

121.55M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

United Therapeutics Research and Development Expense (Quarterly) Chart

Export Data
Save Image

United Therapeutics Historical Research and Development Expense (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 121.55M
Sept. 30, 2013 72.75M
June 30, 2013 54.62M
March 31, 2013 50.43M
Dec. 31, 2012 37.48M
Sept. 30, 2012 65.16M
June 30, 2012 37.10M
March 31, 2012 33.66M
Dec. 31, 2011 48.64M
Sept. 30, 2011 59.43M
June 30, 2011 24.24M
March 31, 2011 47.71M
Dec. 31, 2010 61.92M
Sept. 30, 2010 40.34M
June 30, 2010 28.59M
March 31, 2010 34.87M
Dec. 31, 2009 41.03M
Sept. 30, 2009 31.55M
June 30, 2009 28.65M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Get data for

UTHR Research and Development Expense (Quarterly) Benchmarks

Pluristem Therapeutic 6.107M
Siga Technologies 2.819M
Actelion 106.25M

UTHR Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 24.24M Jun 2011
Maximum 121.55M Dec 2013
Average 48.40M

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.